First Page | Meta Content | |
---|---|---|
![]() | Document Date: 2014-10-01 21:56:23Open Document File Size: 40,10 KBShare Result on FacebookCityTrial / /CompanyPierre Fabre Medicament Australia Pty Ltd / ABC / ITT / /CountryAustralia / /CurrencyUSD / /EventProduct Issues / FDA Phase / /IndustryTermvinorelbine solution / treatment of HER2 positive advanced breast cancer / treatment of advanced/metastatic breast cancer / treatment of advanced breast cancer / /MedicalConditionabdominal pain / solid tumours / Cancer / disease / NSCLC / leukopenia / Stable disease Disease / solid tumors / progressive disease / nausea/vomiting / nausea / tumour / injection site phlebitis / HER2 overexpressing metastatic breast cancer / alopecia / HER2 positive advanced breast cancer / vomiting / fatigue / metastatic breast cancer / metastatic non-small cell lung cancer / non-small cell lung cancer / stable disease / advanced non-small cell lung cancer / neutropenia / febrile neutropenia / advanced/metastatic breast cancer / advanced breast cancer / breast cancer / less progressive disease / /MedicalTreatmentchemo / Chemotherapy / intravenous infusion / /OrganizationTherapeutic Goods Administration / /PositionTrial ID/First author / Private / /ProductVinorelbine capsules / paclitaxel / Navelbine / PBAC’s View Vinorelbine capsules / evidence / HER2 / vinorelbine / /Technologypharmacokinetics / Chemotherapy / /SocialTag |